Kodak Stock Up More Than 1,000% On Deal To Produce Generic Drug Ingredients
The camera giant has been awarded a huge government loan aimed at reducing U.S. reliance on foreign pharmaceutical supply.
Full Article
Kodak Stock Up More Than 1,000% On Deal To Produce Generic Drug Ingredients
Motley Fool
0 shares
1 views
You might like
Related news coverage
Kodak surged 200% to a 30-month high after securing a $765 million government loan to make drug ingredients
Business Insider
**
· *Kodak shares surged 200% on Tuesday after the camera company was awarded a $765 million government loan to make..
-
FTSE 100 clinging on to gains as sterling rallies
Proactive Investors
-
FTSE 100 shrugs off latest episode in US-China muscle-flexing contest
Proactive Investors
-
NA Proactive news snapshot: OTC Markets Group, Cardiol Therapeutics, Talon Metals, CytoDyn, BioSig Technologies, EuroLife Brands UPDATE …
Proactive Investors
-
NA Proactive news snapshot: American Resources, Quantum Computing, GlobeX Data, Bragg Gaming UPDATE …
Proactive Investors
Advertisement
More coverage
Q BioMed has a winner in cancer bone pain drug Strontium89 and a deep pipeline of biomedical assets
Acquires undervalued biomedical assets to accelerate their development Developing drugs and therapies to treat pediatric nonverbal..
Proactive Investors